CB
CanSino Biologics Inc
🇩🇪XSTU.CJHGermanyHealthcare
€2.74EURdown -0.06 (-2.14%)OpenEnd of day12:49 PM
Price€2.74-0.06 (-2.14%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- CNE100003F01
- CUSIP
- Not reported
Company
- Employees
- 1,105
- Headquarters
- Tianjin, Germany
- Website
- https://www.cansinotech.com
- CEO
- Dr. Xuefeng Yu Ph.D.
Market
- Shares outstanding
- 132.7M
- Market cap
- €363.52M
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- €363.52M
- EPS LTM
- -CNÂ¥6.53calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- 14.73%
Fundamentals (LTM)
- Revenue
- CNÂ¥609.52M+44.32%up year on year
- Net income
- -CNÂ¥866.68M+50.84%up year on year
- Gross margin
- 14.38%+104.75%up year on year
- Free cash flow
- -CNÂ¥943.36M+60.52%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.